See up to 3 months of STE. The 7-day demo opens the 1M and 3M ranges and puts STE on your watchlist.
Start 7-day demoLatest STE insider trades
About STERIS plc (STE)
STERIS plc is an SEC registrant, filing under CIK 0001757898, classified as orthopedic, prosthetic and surgical appliances and supplies. It is grouped with Health Care companies on this site.
STE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 4,058 | $957K |
| Grant or award | 13 | 13,475 | |
| Option exercise | 2 | 8,116 | |
STE insider transactions (Form 4)
6378 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Ordinary Shares | 2,199 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 66 footnote F2 | $209.76 | $14K | ||
| Grant or award | Employee Stock Option (right to buy) | 7,668 | $0.00 | - | ||
| ||||||
| Mary Clare Fraser - Officer | Grant or award | Ordinary Shares | 3,009 | $0.00 | - | |
| Mary Clare Fraser - Officer | Tax withholding / forfeiture | Ordinary Shares | 591 footnote F2 | $209.76 | $124K | |
| Mary Clare Fraser - Officer | Grant or award | Employee Stock Option (right to buy) | 10,492 | $0.00 | - | |
| ||||||
| Grant or award | Ordinary Shares | 23,736 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 995 footnote F2 | $209.76 | $209K | ||
| Grant or award | Employee Stock Option (right to buy) | 82,740 | $0.00 | - | ||
| ||||||
| Grant or award | Ordinary Shares | 5,325 | $0.00 | - | ||
| Option exercise | Ordinary Shares | 66 footnote F2 | $209.76 | $14K | ||
| Grant or award | Employee Stock Option (right to buy) | 18,564 | $0.00 | - | ||
| ||||||
| Pierre Boulud - Director | Grant or award | Career Restricted Stock Units | 367 | $0.00 | - | |
| Option exercise | Ordinary Shares | 3,781 | $71.40 | $270K | ||
| Open-market sale | Ordinary Shares | 1,481 | $209.51 footnote F1 | $310K | ||
| Option exercise | Employee Stock Option (right to buy) | 3,781 | $0.00 | - | ||
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 337 footnote F1 | $0.00 | - | ||
| ||||||
| Renato Tamaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 81 footnote F1 | $0.00 | - | |
| ||||||
| Lindsey McGowan - Officer | Tax withholding / forfeiture | Ordinary Shares | 198 footnote F1 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 768 footnote F1 | $0.00 | - | ||
| ||||||
| Julia Madsen - Officer | Tax withholding / forfeiture | Ordinary Shares | 208 footnote F1 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 109 footnote F1 | $0.00 | - | ||
| ||||||
| Mary Clare Fraser - Officer | Tax withholding / forfeiture | Ordinary Shares | 673 footnote F1 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 1,254 footnote F1 | $0.00 | - | ||
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 99 footnote F1 | $0.00 | - | ||
| ||||||
| Cynthia L. Feldmann - Director | Option exercise | Ordinary Shares | 3,098 | $152.32 | $472K | |
| Cynthia L. Feldmann - Director | Open-market sale | Ordinary Shares | 3,098 | $237.21 footnote F1 | $735K | |
| Cynthia L. Feldmann - Director | Option exercise | Director Stock Option (right to buy) | 3,098 | $0.00 | - | |
| ||||||
| Julia Madsen - Officer | Option exercise | Ordinary Shares | 2,872 | $114.22 | $328K | |
| Julia Madsen - Officer | Open-market sale | Ordinary Shares | 2,872 | $262.00 | $752K | |
| Julia Madsen - Officer | Option exercise | Ordinary Shares | 2,136 | $147.05 | $314K | |
| Julia Madsen - Officer | Open-market sale | Ordinary Shares | 2,136 | $262.00 | $560K | |
| Julia Madsen - Officer | Option exercise | Employee Stock Option (right to buy) | 2,872 | $0.00 | - | |
| Julia Madsen - Officer | Option exercise | Employee Stock Option (right to buy) | 2,136 | $0.00 | - | |
| Renato Tamaro - Officer | Open-market sale | Ordinary Shares | 3,324 | $257.43 footnote F2 | $856K | |
| Renato Tamaro - Officer | Open-market sale | Ordinary Shares | 212 | $258.03 footnote F3 | $55K | |
| Renato Tamaro - Officer | Open-market sale | Ordinary Shares | 1,500 | $257.76 | $387K | |
| Renato Tamaro - Officer | Option exercise | Employee Stock Option (right to buy) | 3,536 | $0.00 | - | |
| Renato Tamaro - Officer | Option exercise | Ordinary Shares | 3,536 | $182.22 | $644K | |
| ||||||
| Option exercise | Ordinary Shares | 15,000 | $69.72 | $1.05M | ||
| Open-market sale | Ordinary Shares | 15,000 | $265.14 footnote F2 | $3.98M | ||
| Option exercise | Employee Stock Option (right to buy) | 15,000 | $0.00 | - | ||
| ||||||
| Open-market sale | Ordinary Shares | 159 | $241.82 | $38K | ||
| Tax withholding / forfeiture | Ordinary Shares | 303 footnote F1 | $0.00 | - | ||
| ||||||
| Julia Madsen - Officer | Tax withholding / forfeiture | Ordinary Shares | 52 footnote F1 | $0.00 | - | |
| ||||||
| Mary Clare Fraser - Officer | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F1 | $0.00 | - | |
| ||||||
| Renato Tamaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 26 footnote F1 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 39 footnote F1 | $0.00 | - | ||
| Grant or award | Ordinary Shares | 2,349 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 8,356 | $0.00 | - | ||
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 130 footnote F1 | $0.00 | - | ||
| ||||||
| Tax withholding / forfeiture | Ordinary Shares | 91 footnote F1 | $0.00 | - | ||
| ||||||
| Renato Tamaro - Officer | Option exercise | Ordinary Shares | 3,204 | $147.05 | $471K | |
| Renato Tamaro - Officer | Open-market sale | Ordinary Shares | 3,204 | $249.24 | $799K | |
| Renato Tamaro - Officer | Option exercise | Employee Stock Option (right to buy) | 3,204 | $0.00 | - | |
| Option exercise | Ordinary Shares | 4,110 | $64.05 | $263K | ||
| Option exercise | Director Stock Option (right to buy) | 4,110 | $0.00 | - | ||
| Option exercise | Ordinary Shares | 4,110 | $64.05 | $263K | ||
| Open-market sale | Ordinary Shares | 4,110 | $241.96 | $994K | ||
| Grant or award | Director Stock Option (right to buy) | 2,226 | $0.00 | - | ||
| Grant or award | Career Restricted Stock Units | 772 | $0.00 | - | ||
| Grant or award | Career Restricted Stock Units | 506 | $242.85 | $123K | ||
| Option exercise | Director Stock Option (right to buy) | 4,110 | $0.00 | - | ||
Recent STE Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Breeden Richard C | Director | 4,110 | $953K | View on EDGAR | |
| Sohi Mohsen | Director | 4,058 | $957K |
Stock trades in STE disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
STE insider trading FAQ
What is the latest insider trade for STE?
STERIS plc (STE) had 9 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for STE runs to 78 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STE stock?
No insider purchases of STE were filed in the last 90 days.
How many insiders are selling STE stock?
1 insider sale of STE was filed in the last 90 days, totaling $957K.
Where can I see STE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Karen L. Burton view on EDGAR
- - Mohsen Sohi view on EDGAR
- - Louis Shapiro view on EDGAR
- - Nirav R. Shah view on EDGAR
- - Paul Edward Martin view on EDGAR
- - Christopher S. Holland view on EDGAR
- - Cynthia L. Feldmann view on EDGAR
- - Pierre Boulud view on EDGAR
- - Esther M. Alegria view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where STE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STE with a 7-day demo
- STE on your watchlist
- Every STE Form 4 filing on record
- Up to 3 months of STE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive